INTRODUCTION
late, and it has also been observed that a few uridine or guanidine residues may occasionally disrupt the The encephalomyocarditis-like cardioviruses are posihomopolymer. The Mengo (M strain) poly(C), for examtive-strand RNA viruses (family: Picornaviridae) with a ple, spans 55 nucleotides with a single uridine disconworldwide distribution. Encephalomyocarditis virus tinuity (C 44 UC 10 ), while the tract in EMCV (Rueckert (EMCV), the best characterized member, was originally strain) is longer and has three uridine breaks (C 115 Uisolated from a chimpanzee in 1945 (Helwig et al., 1945) . CUC 3 UC 10 ) (Duke et al., 1992) . In some aphthoviruses, Since then, many other serologically related strains have uninterrupted poly(C) segments of up to 420 nucleobeen described, including Mengo, Columbia-SK, and tides have been documented (Black et al., 1979 ; EscMaus Elberfeld viruses. Studies have shown that infecarmis et al., 1992; Porter et al., 1974) . tion and disease due to EMC-like viruses is common in Although the biological function of the viral poly(C) many species of wild and domestic animals (Grainer, tracts is not entirely clear, our studies with Mengo 1961; Gainer, 1967) . EMCV clinical virus have shown that this region is a major determidisease in humans is rare, although piggeries, primate nant of viral pathogenicity (Duke et al., 1990; Martin colonies, and zoological gardens, among others, have et al., 1996) . Mengo viruses derived from cDNA clones suffered tragic and costly losses due to EMCV infection grew indistinguishably in single-step growth experi- (Zimmerman, 1994) . ments regardless of tract size. But when tested in 4-An unusual characteristic of EMCV-like viruses that week-old mice, the viruses with shortened poly(C) is shared by members of the aphthoviruses is the prestracts were dramatically attenuated for virulence relaence of a homopolymeric, polyribocytidylic acid (potive to the wild-type virus or to a genetically engily(C)) tract within the 5 untranslated sequences (Black neered virus with the wild-type poly(C) tract length et al ., 1979; Perez-Bercoff et al., 1977) . These peculiar (Duke et al., 1990; Martin et al., 1996 ; Palmenberg et poly(C) tracts are retained with fidelity during virus al., 1994) . In mice and other mammals, the short-tract growth in tissue culture and also during passage in Mengo viruses induced protective anti-EMCV antibody animals (Brown et al., 1974) . Among characterized viral responses, suggesting that these isolates could postrains, the specific tract length may vary for each isotentially serve as live, attenuated vaccines against all cardioviruses of the EMCV serotype (Duke et al., 1990; Osorio et al., 1996) . It has been further demonstrated offering the additional possibility of novel, recombiert et al., 1981) , resuspended in a small volume of PBSA (PBS with 0.1% BSA), and then retitered in HeLa cells. nant vaccine vectors (Altmeyer et al., 1994; Altmeyer et al., 1995) .
Histological evaluation We now report an expanded characterization of shorttract Mengo viruses in the natural murine host. SpecifiOne-hundred-eighty 4-week-old Swiss/ICR mice were cally, Mengo viruses containing progressive deletions inoculated intracerebrally with 10 4 PFU of vMwt, vMC 24 , in the poly(C) region were comparatively evaluated for vMD3C 0 D10, or PBSA (20 ml). On Days 0-7, 10, and 15 neurovirulence, brain histopathology, and virus brain ti-PI, five animals from each group were sacrificed and ters. Dose effects and long-term antibody responses their brain tissues harvested. Tissue sections were fixed were also used to assess the immunogenic potential of in 10% formalin, stained with hematoxylin and eosin, and different virus strains. In addition, we have tested the then evaluated microscopically for histological changes reversion potential of a short-tract virus during serial relative to tissues from mock-inoculated animals. A score brain passages in 4-week-old mice.
system, ranging from uninfected/normal (0) to severe meningoencephalitis (///), was used to record the rel-MATERIALS AND METHODS ative severity of virus-induced lesions.
Animals
Minimal protection dose studies One-to 2-day-old, and 4-to 6-week-old BALB/c and Groups of three to five 4-week-old Swiss/ICR mice Swiss/ICR female mice were obtained from breeding colwere inoculated subcutaneously (sc) with 1, et al., 1986) . At 40 days PI, the animals were challenged with 10 6 PFU of EMCV-R by intraperitoneal (ip) inoculaStocks of EMCV Rueckert strain (EMCV-R) and Mengo tion. This dose of EMCV is ú10 3 LD 50 as administered M strain (Mengo-M) virus were amplified in HeLa cells by this route. and concentrated as described (Rueckert et al., 1981) . Recombinant cDNA plasmids, pMwt, pMC 24 , pMC 0 , and Long-term vaccine studies pMD3C 0 D10 with full-length copies of infectious Mengo sequences have been described (Duke et al., 1989; Pal- Groups of five 4-to 6-week-old BALB/c mice were menberg et al., 1994; Martin et al., 1996) . Progeny viruses injected (ip) with 50, 5 1 10 2 , or 5 1 10 3 PFU of vMC 0 . were amplified from plaques obtained after HeLa cell A control group received PBSA only, by the same route. transfections with T7 RNA transcripts derived from these Blood samples were collected from all animals before plasmids (Hahn et al., 1995) . The infected HeLa cell culinoculation, at 2 weeks, and at 1, 3, 6, and 16 months PI tures were clarified by low-speed centrifugation, and the and assayed for the presence of anti-Mengo neutralizing supernatants were titered in standard plaque assays beantibody. Surviving animals were challenged at 16 fore each experiment. months PI with 3 1 10 5 PFU of EMCV-R (i.e., 10 3 LD 50 doses) by ip inoculation.
Virus brain titer assays
Serial passage in 4-week-old mice Thirty-five 4-week-old Swiss/ICR mice were inoculated in the left cerebral hemisphere (ic) with vMD3C 0 D10
Ten 4-week-old Swiss/ICR mice were injected ic with 10 4 PFU of vMC 24 . At 4 days PI, the animals were sacri-(dose: 10 4 plaque-forming units, PFU). At 0-7, 10, and 15 days postinoculation (PI), groups of five animals were ficed, their brains were removed aseptically, and samples were pooled as homogenate suspensions in PBSA euthanized, and the right cerebral hemisphere of each animal was recovered aseptically, weighed, and homog-(10% w/v). Following centrifugation (10,000 rpm for 30 min), supernatants were removed, aliquoted, titered, and enized as a 10% suspension in 0.1% bovine serum albumin (BSA) in sterile water (w/v). After pelleting of cell then designated as passage-1 virus stock (vMC 24 P1). To ensure sufficient virus for a second passage, samples debris by centrifugation (10,000 g for 30 min at 4ЊC), homogenant supernatants were serially diluted and titof this P1 stock were amplified once in HeLa cells (0.1 PFU/cell multiplicity of infection). The HeLa-derived suered for virus on HeLa cell monolayers as described (Rueckert et al., 1981) . If virus was not detected in an pernatants (10 4 PFU) were then injected ic into 10 more 4-week-old Swiss/ICR mice. These animals likewise were undiluted sample (0.1 ml), a parallel sample (1 ml) was reconcentrated by centrifugation through a cushion of sacrificed at 4 days PI, and virus was extracted from their brains as in passage 1. This resultant stock was 30% sucrose in phosphate-buffered saline (PBS) (Rueck- In addition, the relative virulence of these viruses was evaluated over several weeks after ic inoculation of 10
PFU into 4-week-old Swiss/ICR mice.
Virus titer in brain samples
The potential role of poly(C) tract length in the neurovi- at 6-7 days PI (Fig. 1) . In contrast, the brain titers from g Meningitis, diffuse encephalitis, and neuronal death.
animals receiving short poly(C) tract viruses did not increase as rapidly. On Day 1 PI, for example, the mean respectively. Thereafter, the titers of both short-tract vibrain titers for vMC 24 and vMD3C 0 D10 were only 2 1 ruses declined quickly in all animals, and infectivity was 10 2 and 10 3 PFU/ml, respectively (Fig. 1) . undetectable at 7 days PI with the shortest tract virus, A second indicator affected by poly(C) length was the and after 15 days with the vMC 24 virus. Nevertheless, relative maxima of brain titer reached by these viruses even for vMD3C 0 D10, the maximum titers reached by during the assay. Inoculation with vMwt gave mean brain these animals generally met or exceeded the theoretical titers which peaked at 4 1 10 7 PFU/ml on Days 5-6 amount of input inoculum (assuming 100% recovery), pro-PI, whereas vMC 24 and vMD3C 0 D10 reached maximum viding evidence of some viral replication, albeit at low titers of 8 1 10 4 and 10 3 PFU/ml on Days 5 and 2 PI, levels.
Histological studies
The brain tissues of animals infected with vMwt developed significant histological lesions. Acute leptomeningitis was detectable as early as Day 1 PI (Table 1) , and the severity of these lesions increased progressively over time to include infiltration of polymorphonuclear leukocytes, macrophages, and lymphocytes. In addition, necrotic changes such as hyperchromatosis, pyknosis, nuclear fragmentation, and karyorrhexis of groups of nerve cells were detected by 5 -6 days PI (Fig. 2B) . In contrast, by Day 4 PI, the vMC 24 virus had produced only a mild meningoencephalitis with minimal neuronal death and cellular infiltration (Fig. 2C) . Infection with vMD3C 0 D10 gave no detectable meningitis or other encephalitis-associated changes that could be detected by general mi- croscopy (Table 1) , and the brain tissues from these aniThree groups of thirty-five 4-week-old, female mice were inoculated mals were usually indistinguishable from those of con- were examined after subcutaneous inoculation. Two of five mice immunized with 10 2 PFU developed neutralizing antibodies, as did one of five animals receiving either 1 the three animals receiving 10 3 PFU responded with significant levels of neutralizing antibody that were readily or 10 PFU. Upon challenge with EMCV at 40 days PI, all animals that exhibited any level of neutralizing titer were detectable within 10 days PI ( Table 2 ). The third animal from this group also produced neutralizing antibody but protected against pathology (symptoms) and death. The animals that failed to seroconvert (titers õ 20) died of at a reduced titer, detected only after 20 days PI. Of the animals receiving even lower viral doses, four of the EMCV-like disease within 2 weeks after challenge. In a parallel study, BALB/c animals were tested for the DISCUSSION duration of protection after receiving similarly low doses
We have previously shown that genetically engineered of vMC 0 virus. Again, 50 PFU (ip) were sufficient to allow Mengo viruses with short poly(C) tracts are significantly two of five animals to seroconvert with detectable neuattenuated for virulence (LD 50 , 7.9 1 10 6 PFU ic) when tralizing titers of ú1:16 (Table 3 ). Higher doses of inocucompared to wild-type viruses (LD 50 , 9 PFU ic) in 4-weeklum increased the relative number of respondent animals old mice (Duke et al., 1990; Martin et al., 1996) . Animals to three in five for 5 1 10 2 PFU and five in five for 5 1 receiving sublethal doses of vMC 24 developed high levels 10 3 PFU, but did not necessarily increase each groups' of neutralizing antibodies that protected against a norcomposite neutralizing titers. The specific dose response mally lethal challenge of EMCV (Duke et al., 1990) . The differences for particular animals may have been due to virulence, as measured by LD 50 , correlated inversely with simple experimental variation. Alternatively, their repoly(C) tract length (Martin et al., 1996) . With this report, sponses could reflect subtle variations in the genotypes we have now shown that virulence, as measured by disof tested virus (vMC 24 versus vMC 0 ), the mice (Swiss/ ease severity, is also inversely correlated to poly(C) tract ICR versus BALB/c) used in these studies, or even a length. Following intracerebral inoculation, a dose of 10 4 reproducibility distinction between the routes of expo-PFU of vMwt resulted in higher virus brain titers (ú10 6 sure (subcutaneous versus ip). Nevertheless, over the PFU/ml) than those detected in mice inoculated with sim-500-day duration of this experiment (Table 2) , all animals ilar doses of vMC 24 or vMD3C 0 D10. Microscopic examithat continued in the study (one died of natural causes nation of formalin-fixed brain tissue sections also conin each of the 5 1 10 2 and 5 1 10 3 PFU groups) and had firmed that the neuropathogenic properties of these videveloped detectable neutralizing titer (i.e., §16) within the first month PI were also protected from EMCV challenge 18 months after receiving their only exposure to week-old mice (Table 4) .
ruses was directly related to the poly(C) tract length. with an initially small tract (6-35 nucleotides), again had expanded its tract length upon passage in mice (to 75-The vMwt caused a diffuse panencephalitis with severe lesions detectable as early as 1 day PI, whereas vMC 24 140 bases) (McCahon, 1981; Rieder et al., 1993) . In contrast, our short poly(C) tract Mengo isolates passaged infection resulted only in a mild meningitis, and vMD3C 0 D10 did not induce detectable histopathology.
with fidelity both in cell culture and in mice. Five cycles of direct serial brain passage of vMC 24 failed to restore The immunogenic potential of the short poly(C) tract viruses had been previously evaluated, but only after the virulence. Although passaged viruses were not rigorously examined by sequence, we suspect no changes administration of high doses via atypical routes (ic and ip). Those studies showed that vMC 24 was strongly immuin poly(C) length occurred because of the attenuated phenotypes. Twenty cycles of direct passage in cultured nogenic, with inoculated animals developing high titers of anti-Mengo neutralizing antibodies. However, a more macrophages or HeLa cells (Duke et al., 1989) likewise failed to revert the vMC 24 tract length or its virulence. useful evaluation of potential vaccine efficacy was obtained here by administering low doses of viruses and This dichotomy of tract reversion between FMDV and Mengo remains unexplained, though potentially it may using an injection route more common for animal vaccines. Doses as low as 10 2 PFU, inoculated subcutanehave an origin in the high observed recombination frequency observed among FMDVs (McCahon, 1991) . Alterously, induced seroconversion in 80% of recipient animals. Every animal in this study with a detectable neunatively, the short poly(C) Mengo viruses may simply be phenotypically dominant and protectively vaccinate the tralizing serum titer (at least 1:20), was protected. These results are consistent with recent data from a related host before pathogenic revertants can arise and become established. chimeric Mengo virus, administered at similarly low doses (Altmeyer et al., 1995) . In that study, ip inoculation
In either case it is clear that the genetically engineered poly(C) mutations within the Mengo cDNAs have proof only 10 PFU of a vMC 24 -derived virus expressing a portion of the nucleoprotein of lymphocytic choriomeninduced stably attenuated virus strains that seem uniformly unable to produce the devastating pathological effects gitis virus (LCMV) protected more than 80% of recipient BALB/c mice from ic challenge with virulent LCMV (Altof the wild-type viruses. Moreover, these strains also exhibit superb immunogenicity and vaccine potential for meyer et al., 1995) .
In our studies, using a wide range of inocula and long many mammalian species, including primates, and it is possible that we can protectively and safely immunize terms of observation, we have consistently measured the durable persistence of neutralizing antibodies in animals nearly any animal that is subject to cardiovirus infection (gazelles, camels, elephants, lions, etc.) (Zimmerman, receiving any of the short poly(C) tract viruses. Typically, 2-3 log 10 of neutralizing antibodies have been detected 1994). after 2 years PI in a few animals receiving 10 4 -10 6 PFU of vMC 24 (not shown). Without doubt, the remarkable im-ACKNOWLEDGMENTS munogenicity of the short-tract viruses must be related This work was supported by National Institutes of Health Grant AIin some way to a degree of replication in the host. To 30566 to A.C.P and NIH Training Grant GM-07215 to L.R.M. We thank Marchel Hill, Jim Schrader, and Sean Connolly for their valuable technibe sure, after inoculation, these viruses are eventually cal assistance.
cleared by the induced T-cell and B-cell responses (Altmeyer et al., 1994 (Altmeyer et al., , 1995 Neal et al., 1995) , but the low, REFERENCES although detectable, increase in brain titers after injection of the short-tract viruses verifies that these strains
